SARS-CoV-2 SPIKE Antibody Levels can Indicate Immuno-Resilience to Re-infection: a Real-World Study
Abstract Introduction The use of antibody titers against SARS-CoV-2, as a method of estimating subsequent infection following infection or vaccination, is unclear. Here, we investigate whether specific levels of antibodies, as markers of adaptive immunity, can serve to estimate the risk of symptomat...
Saved in:
Main Authors: | Yue Jin, Fei Yang, Christopher M. Rank, Stanley Letovsky, Peter Ramge, Simon Jochum |
---|---|
Format: | Article |
Language: | English |
Published: |
Adis, Springer Healthcare
2024-12-01
|
Series: | Infectious Diseases and Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1007/s40121-024-01090-2 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Protective potential of structural proteins of the SARS-CoV-2 virus in protecting against COVID-19
by: Inna V. Dolzhikova, et al.
Published: (2024-12-01) -
Immunological Approaches and Different Strategies for Vaccine Development Against SARS-COV-2
by: Muhammed Babakir-Mina
Published: (2020-12-01) -
The trend of phylogenetic and epitope variations of SARS-CoV-2 Omicron sub-lineages in Iran
by: Mehdi Shabani, et al.
Published: (2025-01-01) -
Distinct Neutralising and Complement-Fixing Antibody Responses Can Be Induced to the Same Antigen in Haemodialysis Patients After Immunisation with Different Vaccine Platforms
by: Nadezhda Wall, et al.
Published: (2024-12-01) -
Corrigendum: Identifying risk factors for secondary infection post-SARS-COV-2 infection in patients with severe and critical COVID-19
by: Mingquan Guo, et al.
Published: (2025-01-01)